The aim of this study was to evaluate the relationship between the liver stiffness measurement and the risk of developing hepatocellular carcinoma (HCC) in HCV cirrhotic patients undergoing new direct-acting antivirals.
Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life Experience / Rinaldi, L.; Guarino, M.; Perrella, A.; Pafundi, P. C.; Valente, G.; Fontanella, L.; Nevola, R.; Guerrera, B.; Iuliano, N.; Imparato, M.; Trabucco, A.; Sasso, F. C.; Morisco, F.; Ascione, A.; Piai, G.; Adinolfi, L. E.. - In: DIGESTIVE DISEASES AND SCIENCES. - ISSN 0163-2116. - 64:10(2019), pp. 3013-3019. [10.1007/s10620-019-05604-8]
Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life Experience
Guarino M.;Morisco F.;
2019
Abstract
The aim of this study was to evaluate the relationship between the liver stiffness measurement and the risk of developing hepatocellular carcinoma (HCC) in HCV cirrhotic patients undergoing new direct-acting antivirals.File | Dimensione | Formato | |
---|---|---|---|
Rinaldi2019_Article_RoleOfLiverStiffnessMeasuremen.pdf
accesso aperto
Tipologia:
Documento in Post-print
Licenza:
Accesso privato/ristretto
Dimensione
958.97 kB
Formato
Adobe PDF
|
958.97 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.